Westborough, MA, United States of America

Neil J Hayward

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 6.8

ph-index = 3

Forward Citations = 10(Granted Patents)


Location History:

  • Hudson, MA (US) (2016 - 2018)
  • Westborough, MA (US) (2019 - 2024)

Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: The Innovative Journey of Neil J. Hayward in the Field of Therapeutics

Introduction

Neil J. Hayward is a prominent inventor hailing from Westborough, MA, known for his significant contributions to therapeutic innovations. With a robust portfolio of seven patents, he has focused on developing compounds that represent groundbreaking advancements in the medical field.

Latest Patents

Among his notable inventions, Neil's latest patents encompass the formulation of therapeutic compounds and compositions that inhibit Factor XIa or kallikrein. These inventions not only include the innovative compounds themselves but also cover pharmaceutically acceptable salts and various methods of utilizing these therapeutic solutions. His work is poised to have a substantial impact on addressing medical conditions linked to these factors.

Career Highlights

Neil has had a remarkable career working with leading pharmaceutical companies such as Exithera Pharmaceuticals, Inc. and Exlthera Pharmaceuticals, Inc. His experiences in these organizations have allowed him to hone his skills and contribute significantly to the field of therapeutics.

Collaborations

Throughout his career, Neil has collaborated with esteemed professionals, including Frans L. Stassen and Robert Alan Chrusciel. These partnerships have enriched his research and innovation efforts, leading to the development of advanced therapeutic solutions.

Conclusion

In conclusion, Neil J. Hayward stands out as a dedicated inventor in the pharmaceutical landscape, with his patents promising to lead to new and improved treatments. His continuous work reflects a commitment to innovation that serves the healthcare community, and he remains a key figure in the ongoing development of therapeutic compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…